Patents by Inventor Steven Fischkoff

Steven Fischkoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY USING PLACENTAL CELLS
    Publication number: 20220072063
    Abstract: Provided herein are methods of using CD10+, CD34?, CD105+, CD200+ tissue culture plastic-adherent placental cells, e.g. placental stem cells, in the treatment of diabetic peripheral neuropathy (DPN).
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Applicant: Celularity Inc.
    Inventors: Steven FISCHKOFF, Denesh CHITAKARA, Robert J. HARIRI
  • TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS (JRA)
    Publication number: 20130243786
    Abstract: Methods of treating TNF?-related disorders comprising administering TNF? inhibitors, including TNF? antibodies are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: September 19, 2013
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
    Patent number: 7611702
    Abstract: The present invention provides methods for treating adverse events related to immunotherapy. More specifically, the present invention provides methods for treating the enterocolitis associated with anti-CTLA-4 antibody immunotherapy.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: November 3, 2009
    Assignee: Medarex, Inc.
    Inventors: Steven Fischkoff, Israel Lowy, Michael Yellin, James Chung-Yin Yang
  • Method of treating cd30 positive lymphomas
    Publication number: 20090214544
    Abstract: Methods for treating lymphomas characterized by expression of CD30 using anti-CD30 antibodies and steroids in combination are disclosed.
    Type: Application
    Filed: April 25, 2006
    Publication date: August 27, 2009
    Applicant: MEDAREX
    Inventors: Steven Fischkoff, Michael Yellin
  • Treatment of Anemia Using TNFalpha Inhibitors
    Publication number: 20080193466
    Abstract: Methods for treating anemia in which TNF? activity is detrimental are described.
    Type: Application
    Filed: April 14, 2008
    Publication date: August 14, 2008
    Applicant: ABBOTT BIOTECHNOLOGY LTD.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebacca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY
    Publication number: 20070248595
    Abstract: The present invention provides methods for treating adverse events related to immunotherapy. More specifically, the present invention provides methods for treating the enterocolitis associated with anti-CTLA-4 antibody immunotherapy.
    Type: Application
    Filed: November 8, 2006
    Publication date: October 25, 2007
    Inventors: Steven Fischkoff, Israel Lowy, Michael Yellin, James Yang
  • PROPHYLAXIS AND TREATMENT OF ENTEROCOLITIS ASSOCIATED WITH ANTI-CTLA-4 ANTIBODY THERAPY
    Publication number: 20070243184
    Abstract: The present invention provides methods for reducing the incidence of adverse events related to immunotherapy. More specifically, the present invention provides methods for reducing the incidence of enterocolitis associated with anti-CTLA-4 antibody immunotherapy.
    Type: Application
    Filed: November 8, 2006
    Publication date: October 18, 2007
    Inventors: Steven Fischkoff, Israel Lowy, Stephan Targan, James Yang
  • Treatment of spondyloarthropathies using TNFalpha inhibitors
    Publication number: 20070202104
    Abstract: Methods for treating spondyloarthropathies, including ankylosing spondylitis, using TNF? inhibitors are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: August 30, 2007
    Applicant: Abbott Laboratories S.A.
    Inventors: Subhashis Banerjee, Lori Taylor, Clive Spiegler, Daniel Tracey, Elliot Chartash, Rebecca Hoffman, William Barchuk, Philip Yan, Anwar Murtaza, Jochen Salfeld, Steven Fischkoff
  • Assessment of CTLA-4 polymorphisms in CTLA-4 blockade therapy
    Publication number: 20060057626
    Abstract: The invention provides methods for predicting responsiveness of a subject to therapy with a CTLA-4 blocking agent. The methods involve assaying for at least one CTLA-4 polymorphism in the subject and predicting responsiveness of the subject to therapy with a CTLA-4 blocking agent based on presence or absence of a CTLA-4 polymorphic allele in the subject. The methods can further comprise selecting a treatment regimen with a CTLA-4 blocking agent in a subject based upon presence or absence of a CTLA-4 polymorphic allele in the subject. The methods can further comprise administering a CTLA-4 blocking agent to the subject according to the selected treatment regimen. Kits comprising a CTLA-4 blocking agent and means for assaying one or more CTLA-4 polymorphisms, optionally including a vaccine, are also provided.
    Type: Application
    Filed: August 31, 2005
    Publication date: March 16, 2006
    Inventors: Geoffrey Nichol, Michael Yellin, Steven Fischkoff, Jeffrey Weber
  • Treatment of skin and nail disorders using TNFalpha inhibitors
    Publication number: 20040219142
    Abstract: Methods of treating TNF&agr;-related skin and nail disorders are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: November 4, 2004
    Applicants: Abbott Laboratories S.A., Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of metabolic disorders using TNFalpha inhibitors
    Publication number: 20040151722
    Abstract: Methods for treating metabolic disorders, including diabetes and obesity, using TNF&agr; inhibitors are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: August 5, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of vasculitides using TNFalpha inhibitors
    Publication number: 20040136989
    Abstract: Methods for treating vasculitides in which TNF&agr; activity is detrimental are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 15, 2004
    Applicant: Abbott Laboratories S.A.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot Keith Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of anemia using TNFalpha inhibitors
    Publication number: 20040136991
    Abstract: Methods for treating anemia in which TNF&agr; activity is detrimental are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 15, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of pain using TNFalpha inhibitors
    Publication number: 20040136990
    Abstract: Methods for treating pain syndromes in which TNF&agr; activity is detrimental are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 15, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of pulmonary disorders using TNFalpha inhibitor
    Publication number: 20040131614
    Abstract: Methods of treating pulmonary disorders comprising administering TNF&agr; inhibitors, including TNF&agr; antibodies are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 8, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot Keith Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of coronary disorders using TNFalpha inhibitors
    Publication number: 20040126373
    Abstract: Methods for treating coronary disease in which TNF&agr; activity is detrimental are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 1, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of TNFalpha related disorders
    Publication number: 20040126372
    Abstract: Methods of treating TNF&agr;-related disorders comprising administering TNF&agr; inhibitors, including TNF&agr; antibodies are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 1, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Use of anti-TNFalpha antibodies and another drug
    Publication number: 20040009172
    Abstract: The present invention is directed to a method of treating disorders in which TFN&agr; activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor &agr; (hTNF&agr;) in combination with another drug which is useful for treating the disorder. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Kits containing a pharmaceutical composition and instructions for dosing are also encompassed by the invention.
    Type: Application
    Filed: April 24, 2003
    Publication date: January 15, 2004
    Inventors: Steven Fischkoff, Elliot Chartash
  • Use of anti-TNFalpha antibodies and another drug
    Publication number: 20030206898
    Abstract: The present invention is directed to a method of treating disorders in which TFN&agr; activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor &agr; (hTNF&agr;) in combination with another drug which is useful for treating the disorder. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Kits containing a pharmaceutical composition and instructions for dosing are also encompassed by the invention.
    Type: Application
    Filed: April 26, 2002
    Publication date: November 6, 2003
    Inventors: Steven Fischkoff, Elliot Chartash